Cargando…

Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis

BACKGROUND: High bacterial burden in the lung microbiota predicts progression of idiopathic pulmonary fibrosis (IPF). Azithromycin (AZT) is a macrolide antibiotic known to alter the lung microbiota in several chronic pulmonary diseases, and observational studies have shown a positive effect of AZT o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gijs, Pieter-Jan, Daccord, Cécile, Bernasconi, Eric, Brutsche, Martin, Clarenbach, Christian F., Hostettler, Katrin, Guler, Sabina A., Mercier, Louis, Ubags, Niki, Funke-Chambour, Manuela, von Garnier, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204823/ https://www.ncbi.nlm.nih.gov/pubmed/37228285 http://dx.doi.org/10.1183/23120541.00720-2022

Ejemplares similares

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID
por: Funke-Chambour, Manuela, et al.
Publicado: (2021)

αAzithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
por: Krempaska, Kristina, et al.
Publicado: (2020)

Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
por: Krempaska, Kristina, et al.
Publicado: (2020)

Frailty assessment for COVID-19 follow-up: a prospective cohort study
por: Müller, Ilena, et al.
Publicado: (2022)

Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study
por: Guler, Sabina A., et al.
Publicado: (2021)

Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study
por: Lenoir, Alexandra, et al.
Publicado: (2023)

Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case–control study
por: Guler, Sabina A., et al.
Publicado: (2021)

Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts
por: Machahua, Carlos, et al.
Publicado: (2021)

Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies
por: Schertel, Anke, et al.
Publicado: (2017)

Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.
por: Palmieri, Fabio, et al.
Publicado: (2022)

Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC
por: Rindlisbacher, Barbara, et al.
Publicado: (2018)

Recent advances in understanding idiopathic pulmonary fibrosis
por: Daccord, Cécile, et al.
Publicado: (2016)

Evaluation of a Novel Ear Pulse Oximeter: Towards Automated Oxygen Titration in Eyeglass Frames
por: Braun, Fabian, et al.
Publicado: (2020)

Imaging in the aftermath of COVID-19: what to expect
por: Ebner, Lukas, et al.
Publicado: (2020)

Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD
por: Aghapour, Mahyar, et al.
Publicado: (2022)

Evaluating disease severity in idiopathic pulmonary fibrosis
por: Robbie, Hasti, et al.
Publicado: (2017)

Mechanism of azithromycin in airway diseases
por: Yang, Jie
Publicado: (2020)

Autochthonous Case of Pulmonary Histoplasmosis, Switzerland
por: Schmiedel, Yvonne, et al.
Publicado: (2021)

The Octopus Sign—A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis
por: Poellinger, Alexander, et al.
Publicado: (2022)

Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis
por: Boesch, Maximilian, et al.
Publicado: (2020)

Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study
por: Guler, Sabina A., et al.
Publicado: (2022)

Corticosteroid and Azithromycin in Idiopathic Granulomatous Mastitis
por: Salehi, Marzieh, et al.
Publicado: (2017)

The impact of azithromycin therapy on the airway microbiota in asthma
por: Slater, Mariel, et al.
Publicado: (2014)

Why ERS Early Career Members should attend the International Congress 2019 in Madrid
por: Ubags, Niki, et al.
Publicado: (2019)

Remote tissue immune priming in allergic disease
por: Ubags, Niki D.
Publicado: (2020)

The differential effects of azithromycin on the airway epithelium in vitro and in vivo
por: Slater, Mariel, et al.
Publicado: (2016)

Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial Cells
por: Shimizu, Takeshi, et al.
Publicado: (2012)

Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia
por: Arason, Ari Jon, et al.
Publicado: (2019)

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
por: Kewalramani, Namrata, et al.
Publicado: (2022)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Funke-Chambour, Manuela, et al.
Publicado: (2022)

Azithromycin suppressed relapses of idiopathic nephrotic syndrome in a child
por: Hara, Hiromichi, et al.
Publicado: (2018)

Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study
por: Kawamura, Kodai, et al.
Publicado: (2017)

Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis
por: Beigelman, Avraham, et al.
Publicado: (2010)

Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD
por: Kurz, Johanna Manuela, et al.
Publicado: (2021)

Circulating calprotectin levels four months after severe and non-severe COVID-19
por: Abu Hussein, N., et al.
Publicado: (2023)

Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
por: Baines, Katherine J., et al.
Publicado: (2018)

Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses
por: Joelsson, Jon Petur, et al.
Publicado: (2020)

Association of Azithromycin Use With Cardiovascular Mortality
por: Zaroff, Jonathan G., et al.
Publicado: (2020)

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
por: Wollin, Lutz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g11rjiltrrndn1cq86ijaadetk